Results
1
1 companies
Telix Pharmaceuticals
Market Cap: AU$5.3b
A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.
TLX
AU$15.49
7D
-8.0%
1Y
-15.8%
